Jiangsu Bioperfectus Technologies Co. Ltd. Class A

As of June 30, 2026, Jiangsu Bioperfectus Technologies Co. Ltd. Class A carries a market capitalization of 3.81B, placing it among publicly traded companies globally. Its enterprise value stands at 2.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Jiangsu Bioperfectus Technologies Co. Ltd. Class A has 124.13M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Jiangsu Bioperfectus Technologies Co. Ltd. Class A maintains a current ratio of 3.08, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Jiangsu Bioperfectus Technologies Co. Ltd. Class A recorded 12.19M in income tax expense.

As of the close on October 22, 2026, Jiangsu Bioperfectus Technologies Co. Ltd. Class A's stock has declined approximately 51.37% over the past 52 weeks. The 50-day moving average sits at 27.05, while the 200-day moving average is 36.36.

As of June 30, 2026, Jiangsu Bioperfectus Technologies Co. Ltd. Class A holds 1.71B in cash and equivalents against 553.83M in total debt, resulting in a net debt position of 198.53M. Total book value stands at 2.94B, with working capital of 1.23B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Jiangsu Bioperfectus Technologies Co. Ltd. Class A paid dividends of 0.05 per share.

Jiangsu Bioperfectus Technologies Co. Ltd. Class A's most recent stock split took place on July 10, 2026 with a 25:37 split ratio.